Overall Assessment

  • Category 1 – no risk
  • Category II – intermediate risk (Most problamatic)
  • Category III – HIGH RISK (rapid C/S or immediate vaginal delivery)

Category I

7 m

:Include all of the following

  • Baseline rate:110–160 beats/minute-
  • Baseline FHR variability: moderate
  • Late or variable decelerations: absent
  • Early decelerations: present or absent-
  • Accelerations: present or absent - Nonreactive and reactive is cat 1 without stimulation

Category II

FHR tracings include any of the following: Tachycardia

  • Baseline FHR with Absent or minimal or marked variability
  • Absence induced Accelerations after fetal stimulation
  • Recurrent (late or variable) decelerations with moderate variability

After stimulation no reaction is not reassuring and is cat 2

Category III

Category III FHR tracings include either Absent baseline FHR variability and :any of the following

  1. Recurrent late decelerations
  2. Recurrent variable decelerations
  3. Bradycardia
  4. Sinusoidal pattern

Management

CTG is Normal/Reassuring/Category 1

  • Healthy fetus -
  • Continue CTG and normal care ---

Non-Reassuring/Category 2

10 s Think about possible underlying causes.

If the baseline fetal heart rate is over 160 beats/minute, check the woman’s temperature and pulse. If either are raised, offer fluids and paracetamol.

Noninvasive Management

  • A left-lateral position, rule out cord prolapse
  • Give O2 to mother
  • Offer oral or intravenous fluids
  • Discontinue oxytocin until the FHR and uterine activity become normal.
  • Vibroacoustic stimulation (VAS) or fetal scalp stimulation (if reduce variability and or no acceleration)
  • Tocolytic agents: Beta-adrenergic agonists (e.g., terbutaline, subcutaneously can be administered to decrease uterine activity in the presence of uterine tachysystole).
  • Inform coordinating midwife and obstetrician.

Invasive Management

  • Amniotomy: If the FHR cannot be monitored adequately externally, an amniotomy should be performed to place internal monitors.
  • Fetal scalp electrode (FSE)
    • contraindicated in cases of fetal coagulopathy or maternal infections such as HIV, active herpes simplex virus, and hepatitis (B or C). Z

Fetal Scalp Blood pH

(More accurate) Determination of fetal scalp blood pH can clarify the acid-base state of the fetus

  • A pH value of 7.25 or higher is normal-
  • A pH range of 7.20 to 7.24 is a borderline repeat in 30 minute
  • A pH of <7.20 on two measurements 5 to 10-minutes apart may indicate sufficient fetal acidosis to warrant immediate delivery

Category 3 is Abnormal Indicates Need for Urgent Intervention - delivery


Case Studies

166. A 31-year-old woman at 39 weeks of gestation presents with chorioamnionitis in active labor

167. A 21-year-old woman at 31 weeks of gestation is brought to the hospital after a motor vehicle collision

168. A 39-year-old woman at 41 weeks of gestation is completely dilated and effaced and pushing with contractions

169. A 23-year-old woman at 33 weeks of gestation presents to triage with abdominal pain, vaginal bleeding, and a positive urine toxicology screen for cocaine

abruptio placentea

170. A 19-year-old woman at 42 weeks of gestation with limited prenatal care has meconium staining of the amniotic fluid and is in active labor

171. A 27-year-old woman at 38 weeks of gestation with preeclampsia with severe features is admitted for labor induction

Non-reactive